Clonidine Amendment Adopted in WA
On May 7, 2026, Western Australia formally adopted a federal amendment addressing the scarcity of Clonidine.
What happened
The WA Government has enacted the "Therapeutic Goods (Legislative Instruments) Notice (No. 7) 2026" under the Therapeutic Goods Law Application Act 2024. This notice officially incorporates the federal "Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Amendment Instrument 2026" into WA law. The amendment, originally published on the Federal Register of Legislation, responds to the limited availability of Clonidine, a medication primarily used to treat ADHD and high blood pressure. The WA notice acknowledges and applies this federal instrument within the state.
What this means for you
If you are a West Australian patient who relies on Clonidine to manage your ADHD or high blood pressure, this amendment aims to ensure continued access to this medication despite the current scarcity. The specifics of the federal amendment likely outline strategies for managing the shortage, potentially including allowing pharmacists to substitute alternative medications under certain conditions. This means that if Clonidine is unavailable, your pharmacist may be able to provide a suitable alternative without requiring a new prescription from your doctor, ensuring you can maintain your treatment regime.
This type of notice is available via the GovScanner API within minutes of publication. Get started free
What this means for WA
By adopting this federal amendment, the Cook Labor Government signals a proactive approach to addressing medication shortages within the state. This move demonstrates a commitment to aligning WA's therapeutic goods regulations with national standards, particularly in times of crisis. This application under the Therapeutic Goods Law Application Act 2024 establishes a precedent for swiftly incorporating federal measures designed to safeguard public health and pharmaceutical access in Western Australia. It highlights the government's willingness to collaborate with federal bodies to mitigate the impact of drug shortages on vulnerable populations.
The numbers
The "Therapeutic Goods (Legislative Instruments) Notice (No. 7) 2026" was published on May 7, 2026, formally enacting the federal amendment in WA. This action falls under the authority of the Therapeutic Goods Law Application Act 2024, demonstrating the legal framework enabling this adoption. The amendment itself, the "Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Amendment Instrument 2026," directly addresses the scarcity of Clonidine, a drug vital for managing ADHD and high blood pressure. This highlights the government's focus on ensuring access to essential medications for West Australians.
Find your own data
This is just one of thousands of gazette entries GovScanner tracks each year. Search by keyword, industry, location, or minister on the free dashboard โ or connect the API directly to your own tools and let AI do the watching for you.